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Prescription Drug Abuse 
Olivia Lauer & Laura Bray 
Eastern Kentucky University 
 
Abstract: This paper analyzed the prescription drug abuse epidemic among the adolescent 
population through a holistic lens. The prescription drug abuse epidemic has been identified as a 
national and community healthcare issue due to the harmful physiological effects and alarming 
death rates among adolescents in the United States. The current healthcare policies of the federal 
government, pharmaceutical companies, and other various organizations were researched in order 
to evaluate the progress made to counteract the epidemic. In addition to the progress, the possible 
consequences of these newly implemented policies were also reviewed and scrutinized. In response 
to the prescription drug abuse epidemic, a physician accountability system was proposed as a 
potential solution. It was found that the collaborative effort of healthcare practitioners, along with 
new federal guidelines, will decrease access and availability of prescription drugs to adolescents, 
thus, decreasing the number of adolescents abusing prescription drugs in the United States. 
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According to the National Institute on Drug Abuse 
(National Institute of Health [NIH], 2018a), “about 1 in 9 youth 
or 11.4 percent of young people aged 12 to 25 used prescription 
drugs non-medically within the past year” (para. 2). 
Prescription drug abuse includes the usage of prescription drugs 
in a dose other than prescribed, taking another individual’s 
medication, or taking prescription drugs for a nonmedical use 
(NIH, 2018a). Prescription drug abuse can lead to life-threating 
medical consequences including, but not limited to, addiction, 
depression, seizures, overdose, and death (NIH, 2018b).   
National and Community Healthcare issue 
Prescription drug abuse is a major public health problem. 
National data indicates that the nonmedical use of prescription 
drugs has dramatically increased from 2010 to 2018. This 
increase is a reflection of the rise in the number of prescriptions 
issued by physicians to treat chronic pain (DuPont, 2010). The 
three most common classifications of prescription drugs 
misused by adolescents are opioids, central nervous system 
depressants, and stimulants, such as Adderall (NIH, 2018a). 
The misuse of these prescription drugs has severe effects on the 
developing brains and bodies of many adolescents. Indeed, 
these effects can alter areas of the brain that are critical for basic 
functions of life such as heart rate, breathing, and sleeping 
(Elliot et al., 2008). Furthermore, the frequency of misuse or 
abuse of prescription drugs is highly related to addiction and 
other risky behaviors such as smoking and unprotected sexual 
activity.  
Impacts on Delivery of Healthcare 
The World Health Organization (2017) states that “in 2012, 
more than 250 million opioid prescriptions were written in the 
USA, and according to the Center for Disease Control and 
Prevention (CDC), that is more than enough for the entire 
population of 319 million people” (p. 318). Indeed, the 
prescription drug abuse epidemic appears to be directly related 
to physicians increasing their prescribing habits. Therefore, it is 
likely that physicians who overprescribe medications are 
unintentionally enabling prescription drug abusers. In the case 
of prescription opioids, adolescents who receive a legitimate 
prescription from a physician are at an increased risk for future 
prescription drug misuse (NIH, 2018a). Physicians must 
consider alternatives to opioids, and other addictive 
prescription drugs, in order to counterbalance this community 
and national healthcare issue. 
Population Impacted 
The populations most affected by the prescription drug 
abuse epidemic are vulnerable adolescents. The high 
prevalence of prescription drug abuse by adolescents varies due 
to many demographic factors including religion, ethnicity, 
gender, income, education level, geographic location, and ease 
of access (NIH, 2018a). The motivations associated with 
prescription drug abuse also vary between genders. Indeed, 
prior literature indicates that female adolescents are more likely 
to engage in prescription drugs abuse if they are romantically 
involved with a partner who also engages in abuse, and to 
improve their academic performance (Papp & Kouros, 2017). 
Males were more likely to misuse prescription drugs to self-
medicate or get high (Papp & Kouros, 2017).  
Research by Lo, Howell, and Cheng (2013) assessed the 
impact of demographic factors of geographical location and 
education and found the lack of much needed healthcare, 
especially in rural areas, shows a significant association with 
the nonmedical use of prescription drugs. Additionally, the lack 
of education and misinformation regarding the addictive 
properties of prescription drugs is a substantial contributing 
factor to the epidemic among adolescents. Understanding the 
relationship between demographics and the prevalence of 
prescription drug abuse within the community is imperative for 
viewing adolescent abuse holistically.  
Thesis Statement 
The nonmedical use of prescription drugs has become a 
national and community healthcare epidemic for the adolescent 
population, often leading to life-threatening medical 
consequences. This informative paper will examine the abuse 
of prescription drugs by adolescents through a holistic lens, as 
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well as the role that healthcare professionals have in the 
prevention and enablement of prescription drug abuse, and the 
future polices implemented to regulate and prevent prescription 
drug abuse.  
 
Relationship 
Connection to United States Healthcare System 
Healthy People 2020, which was launched in 2010, is a 
public health initiative concerned with achieving optimal 
population health (Shi & Singh, 2019). One of the four 
overarching goals of Heathy People 2020 is to “promote quality 
of life, healthy development, and healthy behaviors across all 
life stages” (Shi & Singh, 2019, p. 82). The topic areas of 
Healthy People 2020 focus on substance abuse and adolescent 
health, which is directly relevant to the prescription drug abuse 
epidemic. Healthy People 2020 uses an action model that 
illustrates how interventions influence determinants of health 
such as individual behaviors, economic status, and access to 
health services (Shi & Singh, 2019). Determinants of health, 
such as access, are directly related to the prevalence of 
adolescents abusing and misusing prescription drugs. A recent 
study by Ford and Lacerenza (2011) examined the relationship 
between adolescents misusing prescription drugs and the 
availability of the source of diversion and access to healthcare. 
They discovered that dependency and misuse of prescription 
drugs by adolescents are strongly correlated with ease of access 
and availability via either friends, dealers, or physicians (Ford 
and Lacerenza, 2011). This correlation supports the significant 
need for public health initiatives, such as Healthy People 2020, 
that review and establish goals toward reducing the access of 
prescription drugs (Shi & Singh, 2019).  
Connection to Occupational Science 
In occupational science, the term occupation is central to 
the discipline. Occupational science is the study of human 
behavior regarding how and why people engage in occupations. 
Addiction, a common consequence of prescription drug abuse, 
prohibits adolescents from participating in everyday valued 
occupations. The initial decision to misuse prescription drugs is 
voluntary for most individuals, but repeated prescription drug 
use leads to chemical changes in the brain which causes 
addiction (NIH, 2018b). Indeed, these changes interfere with 
one’s ability to resist intense urges to take prescription drugs. 
The National Institute on Drug Abuse (2018b) states that “these 
brain adaptions often lead to the person becoming less and less 
able to derive pleasure from thing they once enjoyed, like food, 
sex, or social activities” (para. 5). Addiction controls 
adolescents once valued habits and routines and replaces them 
with occupations centered around urges to engage in drug 
abuse. Prolonged abuse of prescription drugs will affect the 
function of developing adolescent brains and impair learning, 
judgment, decision-making, memory, stress, and behavior 
(NIH, 2018b). Consequently, addiction extinguishes everyday 
adolescent interpersonal roles such as friend, student, 
son/daughter, and brother/sister.  
Connection to Future Role as Healthcare Provider 
All healthcare professionals play a crucial role in 
identifying and preventing nonmedical use of prescription 
drugs. Before healthcare professionals prescribe medication 
such as opioids, the patient should be thoroughly educated on 
the addictive nature of the prescription drug. Occupational 
therapists, as members of the healthcare team, have an 
important role in client education regarding medication 
management, medication storage, and medication disposal 
(Blum & Fogo, 2018). Occupational therapists should educate 
and train clients to modify their habits and routines involved 
with the organization and use of medication (Blum & Fogo, 
2018). Medication management, within the scope of 
occupational therapy, consists of “assessing and treating 
cognition and/or executive function, fine motor coordination, 
vision, health literacy, and the effectiveness of current 
strategies” (Rowe & Breeden, 2018, p. CE-4) to ensure that 
clients can accurately count pills and adhere to their prescribed 
routines. Indeed, logically, these assessments and interventions 
prevent clients from misusing prescription drugs in a dose other 
than prescribed.  
Aside from medication management, occupational 
therapists provide evidence-based, non-pharmacological 
interventions for relieving chronic pain (Rowe & Breeden, 
2018). Occupational therapists use a biopsychosocial treatment 
approach to manage pain rather than treating it with prescribed 
medication. After an extensive review of the literature, the 
major forms of treatment for chronic pain include education 
regarding energy conservation, self-management of pain, 
vocational rehabilitation, biofeedback, passive joint 
mobilization, modalities, splints, and sleep hygiene, as well as 
psychologically-based management strategies such as 
cognitive-behavioral therapy (Robinson, Kennedy, & Harmon, 
2011). These interventions promote alternative forms of 
chronic pain management and are projected to reduce the need 
for prescribed medication (Robinson et al., 2011). Chronic pain 
significantly affects function, and occupational therapists are in 
the unique position to reduce the prescription drug abuse 
epidemic due to their client-centered and holistic approach to 
treatment of chronic pain. 
 
Relevance 
Relevance to Healthcare Policies 
The federal government has responded to the current 
prescription drug abuse epidemic by creating a five-point, 
evidence-based strategy to counteract the current national and 
community crisis. This comprehensive framework includes: 
improving access to prevention, treatment, and recovery 
support services; targeting the availability and distribution of 
prescription drugs; strengthening public health data reporting 
and collection; supporting cutting-edge research that advances 
understanding of pain and addiction; and advancing the non-
pharmacological practice of pain management (NIH, 2017). 
Under the direction of President Donald Trump, the current 
administration recently created a website dedicated to 
confronting the opioid crisis in the United States. According the 
government website, “drug overdose deaths are now the leading 
cause of injury death in the United States” with 63,632 deaths 
from drug misuse and overdose (Trump Administration, 2019). 
The Trump administration is working to address this issue by 
coordinating with healthcare providers to decrease the number 
and strength of addictive drug prescriptions.  
Pharmaceutical manufacturers are in the process of 
creating abuse-deterrent formulations, which are designed to 
https://encompass.eku.edu/kjus/vol4/iss1/5
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prevent individuals from abusing or misusing prescription 
drugs. Current approaches being tested for use are physical or 
chemical barriers, agonist/antagonists combinations, aversive 
substances, delivery systems, and prodrugs (NIH, 2018a). 
Additionally, the federal government is pushing pharmaceutical 
companies to develop safer, non-addictive medication. 
Although safer prescription pharmaceuticals are currently being 
developed, the federal government is mandating that physicians 
comprehensively screen patients for substance abuse disorders 
before providing a prescription for addictive medications 
(Weigel, Donovan, Krug, & Dixon, 2007).  
The Drug Enforcement Administration (DEA), has created 
new federal guidelines that were put into effect in October 
2018. The purpose of these guidelines are to restrict physicians’ 
prescribing habits and limit the distribution and supply of 
prescription drugs. These guidelines include restricting the 
authorization of refills from a 180-day supply to a 90-day 
supply and requiring patients to visit their primary care 
physician before receiving a new prescription (Sullivan, 2018). 
Medical approaches, assessments, and new guidelines such as 
these are projected to dramatically reduce the current 
prescription drug abuse epidemic (Sullivan, 2018).  
Implications to Healthcare Service Delivery 
Preventing the nonmedical use of prescription drugs is a 
collaborative effort from physicians, patients, and pharmacists. 
Physicians are in the position to identify the nonmedical use of 
prescription drugs and take note of rapid increases in the 
amount of medication a patient requests and unscheduled 
medication refills (NIH, 2018a). Although physicians should be 
significantly more cautious due to the recent increase of abuse, 
often times, physicians’ overprescribing habits contribute to the 
rising rates of prescription drug abuse and overdoses. 
Therefore, the federal government and other various 
organizations are creating innovative strategies to reduce 
physician prescribing habits. In order to counteract the rising 
adolescent prescription drug abuse rates, I believe a physician 
accountability system needs to be implemented. Indeed, this 
online system would guarantee that physicians initially attempt 
to prescribe non-addictive forms of medication before 
prescribing opioids or other addictive medications. Because of 
this system, a physician accountability system would 
dramatically reduce the prescription drug abuse epidemic, 
however, some responsibility also remains with the patient.  
Indeed, the patient has the responsibility of safeguarding 
their prescribed medications by taking the appropriate dosage 
for the recommended length of time. To counterbalance the 
current epidemic, patients need to safely store prescription 
medications and never refill any unnecessary prescriptions. 
Additionally, if a patient possesses a surplus of prescribed 
medication, the patient should properly discard the unused 
drugs (NIH, 2018a). Furthermore, before patients refill or 
retrieve their prescribed medications, pharmacists have the 
responsibility of ensuring patient understanding of the 
directions involved when taking their new prescription. This 
collaborative effort from physicians, pharmacists, and patients, 
along with the physician accountability system, will create 
barriers for prescription drug abusers, thus decreasing the 
prescription drug abuse epidemic. 
 
Consequences to Healthcare Service Delivery 
The proposed collaborative effort from healthcare 
practitioners and new federal guidelines will create many 
positive changes to healthcare service delivery, however, like 
any new system, some consequences may arise from these 
recently implemented regulations. Due to these 
implementations, it is likely that the number of teenagers 
abusing prescription drugs will decrease, as well as the number 
of accidental overdoses. However, there are negative 
implications to these new guidelines. For example, the action of 
making strict federal guidelines for prescribing medication such 
as opioids, central nervous system depressants, and stimulates 
may prohibit an individual who actually needs these 
pharmaceuticals from obtaining them. An article detailing the 
DEA states that “the Institute of Medicine estimates that as 
many as 100 million Americans suffer from chronic pain,” and 
they believe the new refill restrictions on prescription drugs will 
prevent Americans who have legitimate needs from receiving 
them (Sulllivan, 2018, para 15). Furthermore, because the 
guidelines require that patients see a primary care physician 
before receiving a new prescription, accessing these drugs now 
requires additional trips to the doctor’s office. This change 
could potentially cost the healthcare system millions of dollars 
and prevent elderly individuals, who have difficulty 
transporting to the doctor’s office, from receiving much needed 
medication (Sullivan, 2018). Nevertheless, the overall benefits 
of these federal restrictions and guidelines on decreasing 
prescription drug abuse outweighs the risks. 
Conclusion 
In conclusion, this informative paper has analyzed the 
prescription drug abuse epidemic and its impact on the 
adolescent population in a holistic perspective. The magnitude 
of this epidemic is viewed as a national and community 
healthcare crisis and a major public health issue that is currently 
being addressed with new regulations and guidelines by the 
federal government and many other organizations. The current 
epidemic has relevance to occupational science and impacts 
both the health care delivery and the future roles of many 
healthcare practitioners, such as occupational therapist, 
physicians, and pharmacist. The collaborative effort of 
healthcare practitioners and the federal government’s 
guidelines will diminish the prevalence of prescription drug 
abuse among adolescents. Indeed, decreasing the access and 
availability of prescription drugs to adolescents will therein 
decrease the number of overall adolescent usage, as well as 
decrease the prescription drug related overdoses in the United 
States. Our generation of healthcare practitioners can be the 
change to end the prescription drug abuse epidemic.   
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